Dueling Attys Call For Xyrem MDL To Be Moved To CA Or NJ

By Julia Arciga · December 3, 2020, 6:46 PM EST

Lawyers for Blue Cross Blue Shield Association and Jazz Pharmaceuticals argued that lawsuits accusing Jazz of paying off rival drugmakers to delay their generic versions of Xyrem, its blockbuster narcolepsy drug,...

To view the full article, register now.

Documents

Case Information

Case Title

Blue Cross and Blue Shield Association v. Jazz Pharmaceuticals, Inc. et al

Case Number

3:20-cv-04667

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

July 13, 2020


Case Title

A.F. of L. - A.G.C. Building Trades Welfare Plan v. Amneal Pharmaceuticals LLC et al

Case Number

7:20-cv-06003

Court

New York Southern

Nature of Suit

Anti-Trust

Date Filed

July 31, 2020


Case Title

IN RE: Xyrem (Sodium Oxybate) Antitrust Litigation

Case Number

2966

Court

Judicial Panel on Multidistrict Litigation

Nature of Suit

Date Filed

August 12, 2020